Kansai Nerolac Paints (500165) Q4 10/11 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 10/11 earnings summary
21 Oct, 2026Executive summary
FY11 gross sales rose 26.4% to Rs. 2,493 crore; net sales increased 25.3%, while profit after tax advanced to Rs. 205.98 crore.
Robust decorative and industrial sales supported results, but raw-material inflation and limited industrial price pass-through weighed on bottom-line growth.
Reported PBT included a Rs. 25.37 crore gain from the sale of the Nipa Chemicals investment; PBT before the exceptional gain was Rs. 263.77 crore.
Financial highlights
Gross sales were Rs. 2,493.19 crore versus Rs. 1,971.71 crore in FY10; net sales were Rs. 2,138.73 crore versus Rs. 1,706.38 crore.
PBT was Rs. 289.13 crore, up from Rs. 238.61 crore; PAT was Rs. 205.98 crore, versus Rs. 165.50 crore.
Operating profit before interest, depreciation, tax and appropriation was Rs. 313.96 crore, compared with Rs. 284.07 crore in FY10.
Other income increased to Rs. 23.46 crore in the accounts; management cited Rs. 48.83 crore including the investment-sale gain, versus Rs. 20.38 crore in FY10.
Proposed dividend was Rs. 10 per share, or 100%, on the doubled share capital after the 1:1 bonus issue; FY10 dividend was Rs. 15 per share.
Outlook and guidance
Near-term top-line and bottom-line growth outlook remained cautious amid cost pressures, market uncertainty, inflation and rising interest rates.
Indian paints market was expected to grow 12–13% annually over the next five years; growth opportunities cited included infrastructure, consumer spending, demographics and GST.
Planned responses included internal cost controls, value-oriented product launches, technology-enabled risk evaluation and capacity expansion at Jainpur and Hosur.
Latest events from Kansai Nerolac Paints
- Cost control and cash generation offset pandemic-driven revenue decline and rising input costs.500165
Q4 20/21 - Cost controls lifted margins and PAT despite lower sales, as COVID-19 clouded the outlook.500165
Q4 19/20 - Revenue grew, profits eased, and acquisitions broadened the portfolio amid cost pressure.500165
Q4 18/19 - Sales and PBDIT advanced as capacity expansion met persistent cost pressures.500165
Q4 17/18 - Sales and operating profit grew as expansion advanced, offset by prior-year land-sale gains in PAT.500165
Q4 16/17 - Normalized profit advanced as growth plans expanded, while land-sale gains lifted reported earnings.500165
Q4 15/16 - FY15 PBT rose 29.9% as industrial coatings gained share and input costs eased.500165
Q4 14/15 - An accounting write-back lifted reported FY13 profit as costs and currency weighed on outlook.500165
Q4 12/13 - Revenue grew 10.8%; capacity investment advanced as input costs and weak demand pressured results.500165
Q4 13/14